CRL vs SHAK · rev $2.00B vs P/E 63, rev $784.4M
Charles River Laboratories (CRL) versus Shake Shack Inc (SHAK) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Shake Shack Inc (SHAK) is a restaurants company listed on NYSE.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
Latest reported SHAK revenue for 2026-07-01 was $784.4M. Net income was $15.4M. SHAK currently screens at market cap $2.62B and trailing P/E 62.6.
CRL currently screens at market cap $7.78B. SHAK currently screens at market cap $2.62B and trailing P/E 62.6.
Not investment advice. Open the CRL and SHAK stock pages for the full models.
Not investment advice.